antagonist therapy of 3-month duration to decrease
post-thrombotic syndrome. [GRADE - 2; LEVEL OF
EVIDENCE - B] We suggest catheter-directed thrombolysis in patients with low bleeding risk with iliofemoral DVT of duration <14 days. [GRADE - 2;
LEVEL OF EVIDENCE - B]
The goal of DVT treatment is twofold: ï¬rst, to prevent venous embolization to